12:00 AM
Jan 14, 2013
 |  BC Week In Review  |  Company News  |  Deals

Galapagos, GlaxoSmithKline deal

Galapagos received an undisclosed milestone payment from GlaxoSmithKline under an amended 2006 deal to discover and develop compounds against autoimmune and...

Read the full 82 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >